Bioventix PLC (BVXP)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1,650.00p

Buy

1,750.00p

arrow-down-50.00p (-2.86%)

Prices updated at 17 Dec 2025, 16:34 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Bioventix PLC is engaged in the field of biotechnology. Its business involves the development of high-affinity sheep monoclonal antibodies and clinical diagnostics and drugs of abuse testing.
FTSE All-Share
arrow-up0.88%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Most recent dividend payment

0.800
Cash Dividend
06 Nov 2025
27 Oct 2025
07 Nov 2025
21 Nov 2025

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20251.5000-0.01
20241.55000.16
20231.52000.19
20221.52000.20
20211.43000.20
20201.41000.20
20191.20000.18
20181.16000.22
20170.91000.21
20160.62500.50

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20257.66-
20244.88-
20233.53-
20223.16-
20213.09-
20202.01-
20192.21-
20181.99-
20172.06-
20163.15-

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20251.5000
20241.5500
20231.5200
20221.5200
20211.4300
20201.4100
20191.2000
20181.1600
20170.9100
20160.6250

% of earnings paid to shareholders data table

YearPayout ratio (%)
2025109.57
2024103.36
202385.92
202278.14
202174.25
202057.28
201958.87
201851.70
201748.57
201656.07
Latest Financial Report as of 16 Dec 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.